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The ubiquitin receptors Rad23 and Dsk2 deliver polyubiquitylated substrates to the proteasome 
for destruction. The C-terminal ubiquitin-associated (uBA) domain of Rad23 functions as a cis-
acting stabilization signal that protects this protein from proteasomal degradation. Here, we 
provide evidence that the C-terminal uBA domains guard ubiquitin receptors from destruction 
by  preventing  initiation  of  degradation  at  the  proteasome.  We  show  that  introduction  of 
unstructured polypeptides that are sufficiently long to function as initiation sites for degradation 
abrogates the protective effect of uBA domains. Vice versa, degradation of substrates that 
contain an unstructured extension can be attenuated by the introduction of C-terminal uBA 
domains. our study gains insight into the molecular mechanism responsible for the protective 
effect of uBA domains and explains how ubiquitin receptors can shuttle substrates to the 
proteasome without themselves becoming subject to proteasomal degradation. 
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T
he  sequence  of  events  that  results  in  the  progressive   
degradation of proteins in the cytosolic and nuclear com-
partments of cells is tightly regulated and coordinated in a   
manner that limits the destructive action to designated substrates 
only, while leaving other proteins unharmed1. Protein substrates 
need to meet at least two requirements for efficient degradation to 
take place. The first prerequisite is that the substrates have to interact 
with the proteasome, a large barrel-shaped complex that harbours 
several proteolytic active subunits2. The canonical targeting signals 
for proteasomal degradation are Lys48-linked polyubiquitin chains 
that are typically conjugated to an internal lysine residue within the   
target protein3.
A more recent study has revealed a second important require-
ment for degradation, namely, the presence of an unstructured ini-
tiation site that is essential to engage the unfolding machinery of 
the proteasome4. Although the compartmentalized nature of the 
proteasome provides an efficient way to confine proteolysis to pro-
teins that are specifically targeted for degradation, it introduces at 
the same time some challenging constraints for substrates5. As the 
entrance of the proteasome particle can only accommodate passage 
of denatured polypeptide strands6, proteins need to be unfolded 
before they  can  be translocated  into  the proteolytic  chamber  of 
the proteasome7. The 19S regulatory particle of the proteasome is 
equipped with six AAA-ATPases that possess unfoldase activity and 
are located at the gate of the proteasome core particle8,9. To initiate 
the process of protein unfolding, the proteasome requires a loosely 
folded initiation site of at least 20–30 amino acids, from which it 
sequentially unfolds and hydrolyzes the protein4,10,11. In metazoan 
cells, the polyubiquitin-selective chaperone AAA-ATPase p97Ufd1/Npl4,   
which has a central role in ubiquitin-dependent proteasomal degra-
dation12, is required for the degradation of folded substrates that 
lack an unstructured polypeptide, suggesting that this complex may 
be able to provide substrates with an unstructured initiation site 
before interaction with the proteasome13.
The budding yeast ubiquitin receptors Rad23 and Dsk2 bind 
polyubiquitylated proteins with their ubiquitin-associated (UBA) 
domains and deliver these substrates to the proteasome for destruc-
tion14. Despite the fact that Rad23 and Dsk2 have to operate in close 
proximity to this proteolytic machinery, these proteins have long 
half-lives, suggesting that their polyubiquitylated cargo is selectively 
degraded by the proteasome, while the ubiquitin receptors them-
selves are left unharmed15,16. We have previously shown that the   
C-terminal UBA2 domain behaves as an intrinsic stabilization signal 
that protects Rad23 from proteasomal degradation17. Substitution of 
a critical leucine residue in the UBA2 domain causes Rad23 to be 
degraded in a manner that is dependent on its N-terminal ubiqui-
tin-like (UbL) domain17, which is known to facilitate the interaction 
with the proteasome16.
In this study, we have investigated, in detail, the protective effect 
of the UBA domains of Rad23 and Dsk2 with respect to the mole-
cular mechanism that allows these ubiquitin receptors to function 
as  reusable  shuttles  for  delivering  polyubiquitylated  proteins  to   
the proteasome.
Results
The UBA domain of Dsk2 functions as a stabilization signal. Dsk2 
shares with Rad23 not only its ability to deliver polyubiquitylated 
proteins to the proteasome14 but also its long half-life15,16, which 
encouraged us to investigate whether the UBA domain of Dsk2 
has a role in protecting this ubiquitin receptor from proteasomal 
degradation analogous to what has been observed for Rad23 (ref. 17).   
To this end, we substituted two conserved leucine residues in the 
UBA domain of Dsk2 for alanine residues in FLAG-tagged Dsk2 
(FLAGDsk2L368,369A).  Notably,  structural  analysis  has  revealed  that 
the leucine at position 369 is part of a hydrophobic patch that is 
important for the typically tightly packed α-helical fold of UBA 
domains18,  and  simultaneous  substitution  of  these  two  adjacent 
leucine residues abolishes ubiquitin binding19. These amino-acid 
substitutions resulted in a strongly reduced steady-state level of the 
mutant protein, as compared with its wild-type counterpart (Fig. 1a).   
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Figure 1 | The UBA domain of Dsk2 functions as a stabilization signal.  
(a) steady-state levels of FLAG-tagged Dsk2 determined by western 
blotting with a FLAG-specific antibody. FLAGDsk2, FLAGDsk2L368,369A and 
FLAGDsk2∆ubL/L368,369A were ectopically expressed from a GAL1 promoter. 
Yeast was grown until early log phase. Wherever indicated, proteasome 
inhibitor was added to a final concentration of 50 µm, 2 h before 
harvesting. β-Actin is shown as loading control. molecular weight markers 
are indicated. Asterisk marks a non-specific band. (b) Turnover of FLAGDsk2 
(closed circles), FLAGDsk2L368,369A (open circles) and FLAGDsk2∆ubL/L368,369A 
(closed squares). samples were taken at the indicated time points and  
probed with a FLAG-specific antibody. Densitometric quantification  
of the western blot is shown. (c) Turnover of FLAGDsk2 (closed circles), 
FLAGDsk2L368,369A (open circles) and FLAGDsk2∆ubL/L368,369A (closed squares) in 
the presence of 50 µm proteasome inhibitor mG132, as shown in b.ARTICLE     
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To test whether the reduced steady-state levels of  FLAGDsk2L368,369A 
were  due  to  proteasomal  degradation,  we  administrated  the 
proteasome  inhibitor  MG132  to  the  yeast  in  a  specific  medium 
that allows efficient uptake of this compound20. Inhibitor treatment 
caused  a  striking  accumulation  of  FLAGDsk2L368,369A,  in  line  with 
efficient proteasomal degradation being responsible for the reduced 
levels (Fig. 1a).  FLAGDsk2L368,369A had a short half-life (Fig. 1b) and 
was stabilized by administration of proteasome inhibitor, consistent 
with efficient proteasomal degradation of the mutant Dsk2 (Fig. 1c). 
Importantly, deletion of the UbL domain also resulted in stabilization 
of the mutant Dsk2, demonstrating that its degradation is largely 
dependent on its proteasome-interacting domain (Fig. 1b).
Different stabilizing potentials of UBA and UIM domains. More 
recently,  it  has  been  shown  that  a  ubiquitin-interacting  motif 
(UIM) in the transcription factor Met4, whose activity is regulated 
in a non-proteolytic manner21 by the conjugation of Lys48-linked 
polyubiquitin chains22, prevents proteasomal degradation of Met4 
(ref. 23). It has been proposed that the UIM domain protects Met4 
by inhibiting ubiquitin chain assembly, allowing only formation of 
polyubiquitin chains that are below the critical length required for 
proteasomal degradation23. To test whether a similar phenomenon 
could be responsible for the protective effect of UBA domains, we 
compared the effects of the wild-type UBA2 domain and the mutant 
UBA2L392A domain, which lacks protective activity17, on ubiquityla-
tion of a well-characterized N-end rule green fluorescent protein   
(GFP)  substrate,  ubiquitin–arginine–GFP  (Ub-R-GFP)24,25.  Ubi-
quitylated  proteins  were  precipitated  under  reducing  conditions 
to  avoid  contaminations  with  polyubiquitylated  proteins  bound 
to the UBA domain. We observed a very similar polyubiquityla-
tion pattern for the reporter substrates, irrespective of the nature 
of the UBA domain (Fig. 2a). As the polyubiquitylation pattern was 
comparable in substrates carrying either the protective or mutant 
UBA domain, inhibition of ubiquitin chain elongation cannot fully 
explain the ability of UBA domains to protect substrates from pro-
teasomal degradation.
We next compared side-by-side the protective effects of the UBA2 
domain of Rad23, the UBA domain of Dsk2 and the UIM of Met4 
in the context of the Ub-R-GFP reporter substrate. For the latter, we 
used a fragment of Met4 consisting amino acids 75–160 (Met475–160), 
which includes the earlier identified UIM23 and has been shown to 
be able to inhibit proteasomal degradation26. In striking contrast to 
the UBA domains, the UIMMet4 had no effect on the stability of the N-
end rule reporter substrate. The low steady-state level of the reporter 
carrying the UIMMet4 was a result of efficient proteasomal degrada-
tion, as demonstrated by flow cytometric (Fig. 2b) and western blot 
analysis (Fig. 2c) of yeast expressing the fusions in the absence or 
presence of proteasome inhibitor. The differences of the protective 
effects of the UBA domains and the Met4 UIM in the context of 
the N-end rule reporter substrate suggest that divergent molecular 
mechanisms are responsible for the ability of these ubiquitin-binding   
domains to protect proteins from proteasomal degradation.
A C-terminal UBA1 domain does not protect from degradation. 
The protective UBA domains of Rad23 and Dsk2 are localized at the 
C termini of these proteins. We wondered whether the positioning 
of the UBA domains was of significance for their ability to protect 
substrates from proteasomal degradation. To address this issue, we 
swapped the internal UBA1 domain and C-terminal UBA2 domain 
within the Rad23 protein (Fig. 3a). We first replaced the C-terminal 
UBA2 domain with the UBA1 domain, giving rise to a Rad23 with 
two UBA1 domains (Rad23UBA1/UBA1). Next, we replaced the internal 
UBA1 domain with the UBA2 domain to generate Rad23UBA2/UBA1,   
in which the two domains had been swapped. Expression of wild- 
type  Rad23UBA1/UBA2,  and  the  two  variants  Rad23UBA1/UBA1  and 
Rad23UBA2/UBA1, in yeast revealed that the UBA1 domain is unable to   
protect even when placed at the same C-terminal position as the 
UBA2 domain (Fig. 3b). Furthermore, placing the UBA2 domain 
at the internal position inactivated its stabilizing potential, as evi-
denced by the efficient proteasomal degradation of the Rad23UBA2/UBA1   
variant. Taken together, there are two important conclusions from 
this experiment. First, it confirmed, now in the context of Rad23, our 
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Figure 2 | Different stabilizing potentials of UBA and UIM domains. 
(a) ub-R-GFP-uBA2 and ub-R-GFP-uBA2L392A were expressed in 
yeast together with His-tagged ubiquitin. ubiquitylated proteins were 
precipitated using ni beads and probed with a GFP-specific antibody. 
Input (I) and precipitated (P) samples are shown. ub-R-GFP-uBA2 and 
ub-R-GFP-uBA2L392A are indicated. note that the upper band in the ub-R-
GFP-uBA2 corresponds with diubiquitylated ub-R-GFP-uBA2. molecular 
weight markers are indicated. (b) Relative fluorescence levels of yeast 
expressing the ub-m-GFP, ub-R-GFP, ub-R-GFP-uBA2Rad23, ub-R-GFP-
uBADsk2 and ub-R-GFP-uImmet4 analysed by flow cytometry. ub-m-GFP 
was standardized as 100%. Values are means and standard deviations 
(n = 3). *P < 0.05, **P < 0.01 (student’s t-test). (c) Western blot analysis 
with GFP-specific antibody of steady-state levels of ub-m-GFP, ub-R-GFP, 
ub-R-GFP-uBA2Rad23, ub-R-GFP-uBADsk2 and ub-R-GFP-uImmet4 in the 
absence or presence of 50 µm proteasome inhibitor mG132. note that 
the upper bands correspond with diubiquitylated ub-R-GFP-uBA2Rad23 
and putative monoubiquitylated ub-R-GFP-uBADsk2. β-Actin is shown as 
loading control. molecular weight markers are indicated. specific bands are 
indicated with arrowheads.ARTICLE
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earlier conclusion17 that the UBA1 domain is unable to function as a 
stabilization signal. Second, these data show that the UBA2 domain 
can only protect from proteasomal degradation when positioned at 
the C terminus, which corresponds with its native location.
A conserved motif contributes to the protective effect. We were 
intrigued by the fact that the UBA1 and UBA2 domains displayed 
such a striking difference in their ability to protect proteins from 
proteasomal degradation, despite their structural resemblance. Both 
domains adopt a fold with three tightly packed α-helix bundles in a 
conformation that is characteristic of UBA domains27. In an attempt 
to pinpoint the difference between the domains responsible for the 
divergent  effects  on  proteasomal  degradation,  we  generated  chi-
meric UBA domains in which fragments containing the first, second 
and third helices from the UBA1 and UBA2 domains were com-
bined (Fig. 4a). We found that most C-terminal helices of the UBA2 
domain could be replaced with the equivalent fragment of the UBA1   
domain, with only a modest impact on its protective effect, whereas 
the first and the second helices appeared to be more important for 
the stabilizing effect (Fig. 4b). Notably, the loop between the first 
two helices contains a highly conserved motif (Xaa-Gly-Phe/Tyr-
Xaa) that is found to be important for specific binding events27 as 
well as for ubiquitin-binding-assisted conformational switch28. We 
noticed that all protective UBA domains so far tested harboured 
a phenylalanine residue in this motif, whereas the UBA1 domains 
from Rad23 and the human homologue Rad23-A (hHR23A), which 
are both unprotective17, had a tyrosine residue at the same position 
(Fig. 4c). Remarkably, we found that replacing the tyrosine residue 
in this motif in the UBA1 domain with a phenylalanine residue 
resulted in a UBA1 domain that significantly increased the steady-
state levels of the reporter substrate, although not to the same extent 
as the wild-type UBA2 domain (Fig. 4d). Turnover analysis showed 
that this single amino-acid substitution in the UBA1 domain indeed 
prolonged the half-life of the substrate (Fig. 4e). Our data suggest 
that the protective effect of the UBA2 domain is an intrinsic feature 
and identifies a well-conserved motif as a contributing factor.
C-terminal unstructured polypeptides abrogate protection. The 
importance of the C-terminal position of the UBA2 domain, com-
bined with our earlier observation that the structural stability of 
mutant UBA domains of human p62 correlates with their protective 
effect29, raised the question of whether these domains can interfere 
with protein unfolding. Using designed substrates, it has previously 
been shown that proteasomes, when interacting with protein com-
plexes, display a strong preference for those proteins that contain 
unstructured initiation sites30. Consistent with a critical role for pre-
venting initiation of protein degradation, we found that introduc-
tion of a 34-amino-acid-long polypeptide, which is sufficiently long 
to function as an initiation site for proteasomal degradation10,11, 
strongly reduced the stabilizing effect of the UBA2 domain, result-
ing in low steady-state levels and accumulation of the reporter sub-
strate in the presence of the proteasome inhibitor MG132 (Supple-
mentary Fig. S1). Promoter shut-off experiments showed that the 
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Figure 3 | A C-terminal UBA1 domain does not protect from degradation. 
(a) schematic drawing of the positions of the uBA1 and uBA2 domains 
in wild-type Rad23 (Rad23uBA1/uBA2), Rad23uBA1/uBA1 and Rad23uBA2/uBA1. (b) 
steady-state levels of FLAG-tagged Rad23uBA1/uBA2 (wild-type), Rad23uBA1/uBA2*  
(Rad23L392A), Rad23uBA1/uBA1 and Rad23uBA2/uBA1 were determined with a 
FLAG-specific antibody. Arrows indicateFLAGRad23 bands. β-Actin is shown 
as loading control. molecular weight marker is indicated. Asterisk indicates 
a non-specific band. 
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Figure 4 | A conserved motif contributes to the protective effect.  
(a) schematic representation of the generation of chimeric uBA1/uBA2 
domains. (b) Relative fluorescence levels of yeast cells expressing ub-R-
GFP with C-terminal uBA1, uBA2 and chimeric uBA domains analysed 
by flow cytometry. Values are means and standard deviations (n = 3). 
*P < 0.05, **P < 0.01 (student’s t-test). (c) Alignment of the Xaa-Gly-Phe/
Tyr-Xaa motif in the loop between helix 1 and helix 2 of a number of uBA 
domains. (d) Relative fluorescence levels of yeast cells expressing ub-R-
GFP-uBA1, ub-R-GFP-uBA1Y160F, ub-R-GFP-uBA2 and ub-R-GFP-uBAF369Y 
analysed by flow cytometry (the numbers refer to positions of these 
amino acids in Rad23). Values are means and standard deviations (n = 6). 
*P < 0.05, **P < 0.01 (student’s t-test). (e) Turnover of ub-R-GFP-uBA1 and 
ub-R-GFP-uBA1Y160F. samples were taken at the indicated time points and 
probed with a GFP-specific antibody.ARTICLE     
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half-life of the fusion harbouring the extension was substantially 
reduced (Fig. 5a).
We next investigated this phenomenon in the context of the 
native Rad23 protein and found that introduction of the C-terminal 
unstructured extension also converted the stable Rad23 to an effi-
ciently degraded substrate of the proteasome (Fig. 5b). Importantly, 
degradation  of  Rad23  carrying  the  unstructured  extension  was 
dependent on its UbL domain (Fig. 5b). Whereas Rad23 remained 
stable over the 40-min time frame analysed, protein levels of the 
fusion carrying the unstructured extension were undetectable after 
10 min (Fig. 5c). To investigate the minimal length requirement for 
the  C-terminal  extension,  we  truncated  the  33  amino-acid-long   
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Figure 5 | C-terminal unstructured polypeptides abrogate protection. (a) Turnover of ub-R-GFP, ub-R-GFP-uBA2, ub-R-GFP-uBA2L392A and ub-R-GFP-
uBA2-V5His. samples were taken at the indicated time points after switching off the expression and probed with a GFP-specific antibody. (b) steady-
state levels of FLAGRad23, FLAGRad23-V5His and FLAGRad23-V5His∆ubL in the absence or presence of the proteasome inhibitor mG132. β-Actin is shown as 
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unstructured polypeptide to generate fusion proteins with exten-
sions consisting of 25, 20 and 15 amino acids. Whereas the 25 and 20 
amino-acid-long extensions resulted in efficient proteasomal degra-
dation of Rad23, the stability of the fusion carrying the 15 amino-
acid-long extension was comparable with the stability of wild-type 
Rad23 (Fig. 5d). Thus, an extension consisting of at least 20 amino 
acids is required to facilitate proteasomal degradation, which cor-
responds with the minimal length requirement for unstructured 
initiation  sites10,11.  We  conclude  that  introduction  of  C-terminal 
polypeptides that are sufficiently long to function as unstructured 
initiation sites abrogate the protective effect of the UBA2 domain.
UBA domains can shield an internal unstructured polypeptide. 
We observed that efficient proteasomal degradation of an UbL–GFP 
fusion (Fig. 6a) is strictly dependent on the presence of an unstruc-
tured polypeptide (Fig. 6b,c). Interestingly, positioning of the UBA2 
domain at the C-terminal end of the extension resulted in a strong 
inhibition of proteasomal degradation of the UbLRad23 fusion (Fig. 
6b,c). Whereas the UBA2 domain blocked degradation of the fusion, 
the UBA1 domain did not have any noteworthy effect on its stability. 
Turnover experiments clearly showed that the C-terminal position-
ing of the UBA2 domain, but not the UBA1 domain, resulted in an 
extended half-life similar to the fusion that lacked an unstructured 
polypeptide (Fig. 6d). Similarly, we found that the UBA domain of 
Dsk2 protected the UbLDsk2–GFP carrying an unstructured polypep-
tide from proteasomal degradation (Supplementary Fig. S2). The 
above data strongly suggest that UBA domains hinder the genera-
tion of an unstructured initiation site for degradation and provide 
an explanation for the importance of the C-terminal position for 
UBA-mediated protection from proteasomal degradation.
Protective UBA domains cannot function as initiation sites. Our 
observations that Rad23 variants, in which the C-terminal UBA2 
domain has been mutated, are subjected to proteasomal degrada-
tion suggest that mutant UBA domains not only fail to protect but 
can also function as initiation sites. We tested this possibility by pro-
viding the UbLRad23–GFP with the UBA2 or UBA2L392A domain of 
Rad23 and the UbLDsk2–GFP with the UBA or UBAL368,369A of Dsk2 
(Fig. 7a). Consistent with this model, we found by flow cytometric 
(Fig. 7b) and western blot analysis (Fig. 7c,d) that the UBA domains 
could be clearly divided into two groups: (i) the mutant UBA2L392A  
and  UBAL368,369A  domains,  which  facilitated  degradation  of  the   
UbL-targeted  proteins,  and  (ii)  the  protective  UBA  domains  of   
Rad23 and Dsk2, which did not cause degradation of UbL-targeted   
proteins.  These  findings  suggest  that  protective  UBA  domains 
prevent protein degradation through their inability to function as 
unstructured initiation sites for protein degradation.
Discussion
Our data strongly suggest that C-terminal UBA domains protect 
ubiquitin receptors from proteasomal degradation by preventing 
the generation of initiation sites for degradation, which are required 
for proper engagement of the inherent unfolding machinery of the 
proteasome4 (Fig. 8). The molecular mechanism that is proposed in 
this study is fundamentally different from the inhibition of ubiquitin 
chain elongation by which the UIM domain has been suggested to 
protect Met4 from degradation23. The implication of distinct mech-
anisms may seem surprising given that the UIM and UBA domain 
are  structurally  unrelated  and  have  little  in  common  except  for 
their ability to selectively bind polyubiquitin chains. However, it is 
noteworthy that several properties of the involved proteins already 
argued against a shared mode of action. First, whereas the UIM pre-
vents binding of Met4 to the proteasome23, Rad23 and Dsk2 need 
to physically interact with the proteasome in order to deliver their 
polyubiquitylated cargo14. Second, the UbL domains of Rad23 and 
Dsk2 bind directly to the Rpn1 subunit of the proteasome without 
the need for polyubiquitin modifications31,32, suggesting that block-
ing of polyubiquitylation will be inadequate to prevent binding of 
Rad23 and Dsk2 to the proteasome. Third, we recently showed that 
the structural stability rather than the ubiquitin binding properties 
of UBA domains is a critical determinant for their ability to pro-
tect from proteasomal degradation29. Fourth, the UBA domains in 
Rad23  and  Dsk2  bind  polyubiquitylated  proteins  designated  for 
delivery at the proteasome14, which is hard to reconcile with a role 
of the very same domains in preventing proteasomal degradation 
by inhibiting ubiquitylation of the ubiquitin receptors themselves, 
as this would require simultaneous binding of ubiquitin chains con-
jugated to the ubiquitin receptor (to prevent chain elongation) and 
polyubiquitylated proteins (for delivery to the proteasome).
The ubiquitin receptors Rad23 and Dsk2 are central players in 
ubiquitin-dependent proteasomal degradation since they, together 
with a few other substrate adaptors, are responsible for the delivery   
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Figure 7 | Protective UBA domains cannot function as initiation sites. 
(a) schematic drawing of the ubL-GFP fusions. (b) Flow cytometric 
quantification of the mean fluorescence intensities of yeast expressing 
ubLRad23-GFP-uBA2, ubLRad23-GFP-uBA2L392A, ubLDsk2-GFP-uBA or 
ubLDsk2-GFP-uBAL368,369A. ubLRad23-GFP-uBA2 and ubLDsk2-GFP-uBA were 
standardized as 100%. Values are means and standard deviations (n = 3). 
**P < 0.01 (student’s t-test). (c) Turnover of ubLRad23GFP-uBA2 (closed 
circles) and, ubLRad23GFP-uBA2L392A (open circles). samples were collected 
at the indicated time points and detected with a GFP-specific antibody. 
Densitometric quantification of the blot is shown to the right. (d) Turnover 
of ubLDsk2-GFP-uBA (closed squares) and ubLDsk2-GFP-uBAL368,369A 
(open squares). samples were collected at the indicated time points and 
analysed by western blotting with a GFP-specific antibody. Densitometric 
quantification of the blot is shown to the right.ARTICLE     
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of polyubiquitylated substrates to the proteasome33. The question 
remains if a similar protective effect is also involved in rescuing 
other ubiquitin receptors from proteasomal degradation. The ubiq-
uitin-binding subunit Rpn10, which is an integral part of the 19S 
regulator and important for the structural integrity of this com-
plex34, is of particular interest as it carries a C-terminal UIM motif35, 
similar to the domain that protects Met4 from proteasomal degra-
dation23. While our data show that Met4’s UIM, unlike the protec-
tive UBA domains, is unable to safeguard reporter substrates from 
proteasomal degradation, it is difficult to directly extrapolate these 
findings  to  Rpn10.  Although  a  recent  report  provided  evidence 
that Rpn10 is polyubiquitylated and degraded by the proteasome36, 
which would support the idea that the UIM domain lacks a protec-
tive effect, we feel that further research is required as it can presently 
not be excluded that a possible protective effect of the UIM is regu-
lated and becomes only apparent under specific conditions. Indeed, 
only recently has been found that Rpn10 is monoubiquitylated in 
a UIM-dependent manner and that this modification is important 
for its role in protein degradation37, suggesting that the interplay 
between ubiquitylation and Rpn10 may be more complicated than 
originally anticipated.
An intriguing finding remains the observation that the inter-
nal UBA1 domain of Rad23 is unable to protect from proteasomal 
degradation17, even when positioned at the C terminus of Rad23, 
despite the fact that it shares its structural conformation27 and 
its ability to bind ubiquitin38 with the protective UBA2 domain. 
We found that a previously identified conserved motif27, which 
is present in the loop between the first two helices, partly deter-
mines the ability of the UBA2 domain to prevent degradation. 
Interestingly, it has been previously shown that this motif is not 
only involved in ubiquitin binding but also explains the selective 
binding of several proteins to the UBA2 domain of hHR23A39–41. 
Although ubiquitin binding is not a critical determinant for the 
protective  effect29,  our  data  do  not  exclude  a  contributing  role 
for binding of ubiquitin or other proteins to UBA domains. In 
this respect, it is noteworthy that the UBA2 domain of hHR23A 
is able to bind two Lys48-linked ubiquitin molecules simultane-
ously,  resulting  in  a  structure  in  which  the  ubiquitin-binding 
domain  is  sandwiched  in  between  two  ubiquitin  monomers42. 
It is feasible that the closed conformation of this complex may 
further hinder the unfolding by either stabilizing the structure 
or  by  making  the  C  terminus  of  the  UBA  domain  less  acces-
sible for the unfoldase machinery. Moreover, UBA domains can   
prevent ubiquitin chain elongation43,44 and our data are compatible   
with a contributing role for this mode of action in particular, as suf-
ficiently long polyubiquitin chains may otherwise allow the polyu-
biquitin-dependent chaperone p97/Cdc48Ufd1/Npl4 complex to assist 
in protein unfolding by generating alternative initiation sites13.
It is intriguing that the UIM and UBA domains target two inde-
pendent events that are both critically required for efficient pro-
teasomal degradation. The distinct roles of the transcription fac-
tor Met4 and the ubiquitin receptors Rad23 and Dsk2, respectively, 
may provide a plausible explanation for why these two steps are 
targeted by the respective domains. The modification with Lys48-
linked polyubiquitin chains of Met4 regulates its activity in a non-
proteolytic manner without implicating the proteasome21,22; hence, 
preventing  Met4  from  interacting  with  the  proteasome  appears 
to be an efficient and robust way to avoid its degradation. On the 
contrary, Rad23 and Dsk2 need to interact with the proteasome 
in order to deliver their cargo14, making any type of interference 
with proteasome binding incompatible with their role in ubiquitin-
dependent proteolysis. Instead, our data suggest that these proteins 
are shielded from the destructive activities of the proteasome by 
elements that prevent the initiation of degradation, a mechanism   
that is compatible with the observed transient interactions of ubi-
quitin receptors with the proteasome. The demonstration of diver-
gent actions, targeting both substrate recruitment and unfolding, 
that allow ubiquitin-binding domains to interfere with the degrada-
tion of their corresponding proteins, highlights the intricate inter-
play between these domains and ubiquitin-dependent proteolysis 
and opens new avenues to probe into the molecular mechanisms 
that distinguish the fates of proteasome-interacting proteins from 
those of substrates.
Methods
Yeast strains and media. The experiments were performed in haploid derivates of 
strain DF5 (lys2-801, leu2-3, -112, ura3-52, his3-∆200, trp1-1). Yeast transformed 
with episomal plasmids with GAL1 promoters was grown successively in synthetic 
medium with glucose, raffinose and galactose as sole carbohydrate source. For 
proteasome inhibition experiments, synthetic medium with 0.1% proline as sole 
nitrogen source was used20. The cultures were supplemented with 0.003% SDS in 
early mid-log phase, before the proteasome inhibitor MG132 (Z-Leu-Leu-Leu-
CHO, Biomol) was added at an OD600 of 0.6 for 2 h at a final concentration of 
50 µM (ref. 20).
Construction of plasmids. Yeast expression plasmids were generated by PCR, 
amplifying the open reading frames from genomic yeast DNA and introducing 
flanking restriction sites, which were used for subcloning them into the yeast  
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Figure 8 | Model for UBA-mediated protection from proteasomal degradation. (a) The schematic drawing shows an ubiquitin receptor (Rad23/Dsk2) 
that delivers a ubiquitylated substrate to the 26s proteasome. The ubiquitin receptor binds the proteasome through its n-terminal ubL domain that 
directly interacts with the Rpn1 subunit of the proteasome, thereby delivering the polyubiquitylated substrate bound to the uBA domain. Wild-type 
Rad23/Dsk2 contains a C-terminal uBA domain that resists initiation of protein degradation, resulting in release of the ubiquitin receptor from the 
proteasome. (b) In case the ubiquitin receptor has a mutant uBA domain or is provided with a polypeptide that can function as an unstructured initiation 
site, the ubiquitin receptor itself is translocated into the proteasome and hydrolyzed in the proteolytic chamber.ARTICLE
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expression vectors pYES2 (2µ, URA3; Invitrogen) or pYES3 (2µ, TRP1;  
Invitrogen). All constructs were verified by DNA sequencing.
Protein analysis. Total protein extracts of cultures in mid-log phase were obtained 
by lysis and precipitation in trichloroacetic acid. For GAL1 promoter shut-off 
experiments, transcription and translation were arrested by adding glucose and 
cycloheximide (Sigma) to final concentrations of 2% and 1 mg ml − 1, respectively. 
Aliquots were taken at the indicated time points and total protein extracts were 
prepared. Samples were heated for 10 min at 95 °C, subjected to SDS-PAGE and 
analysed by western blotting.
Flow cytometric analysis. Cultures were grown in galactose until mid-log phase 
and subjected to flow cytometric analysis on a FACScalibur (Beckton & Dickin-
son). Data were analysed with CellQuest software.
Western blot analysis. Total lysates were separated by SDS-PAGE and transferred 
onto nitrocellulose membranes (PROTRAN; Schleicher & Schuell). The mem-
branes were blocked in phosphate-buffered saline supplemented with 5% skim 
milk and 0.1% Tween-20 for 1 h. This was followed by probing the membranes with 
monoclonal antibodies mix (Roche) or polyclonal antibodies (Invitrogen) specific 
to GFP in a 1:2,000 dilution for 1 h or a monoclonal antibody specific to the FLAG 
epitope (M5; Sigma) in 1:2,000 dilution for 1 h. After subsequent washing steps 
and incubation with peroxidase-conjugated goat anti-mouse or anti-rabbit serum, 
respectively (GE Healthcare), the membranes were developed by enhanced  
chemiluminiscence (GE Healthcare).
Detection of ubiquitylated proteins. Total yeast lysates of cultures (200 OD600 
units) in mid-log phase expressing His-tagged ubiquitin were obtained by lysis and 
precipitation in NaOH and trichloroacetic acid. Binding to Ni-NTA beads (Qia-
gen) was performed under denaturing conditions in buffer A (6 M guanidinium 
chloride, 100 mM NaH2PO4, 20 mM imidazole, 10 mM Tris (pH 8.0) and 0.05% 
Tween20) at 4 °C for 16 h. After subsequent washing with buffer A and buffer C 
(8 M urea, 100 mM NaH2PO4, 10 mM Tris (pH 6.3) and 0.05% Tween20), the beads 
were eluted in 1% SDS at 65 °C for 10 min. The samples were next heated  
and subjected to SDS-PAGE for western blotting. 
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